BioSapien, the pioneering biotech company behind MediChip announces a new extension to its pre-Series A funding round and the appointment of new talent across the business, including Joseph Borrello, ...
BioSapien, the patented drug delivery platform treating cancer ‘locally’, announces its $5.5 million (20.2M AED) pre-Series A fundraise. The funding was led by Global Ventures – MENA’s leading VC firm...